EUVIMEDEUVIMED entdecken
Crossref

Estimation of the odds ratio from multi‐stage randomized trials

Shiwei Cao, Sin-Ho Jung iD

Pharmaceutical Statistics · 2024

DOI: 10.1002/pst.2378 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmaceutical Statistics, 2024. Verfasst von Shiwei Cao und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Randomized Controlled Trials as Topic, Research Design, Bias, Clinical Trials, Phase II as Topic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 18 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A multi‐stage design for a randomized trial is to allow early termination of the study when the experimental arm is found to have low or high efficacy compared to the control during the study. In such a trial, an early stopping rule results in bias in the maximum likelihood estimator of the treatment effect. We consider multi‐stage randomized trials on a dichotomous outcome, such as treatment response, and investigate the estimation of the odds ratio. Typically, randomized phase II cancer clinical trials have two‐stage designs with small sample sizes, which makes the estimation of odds ratio more challenging. In this paper, we evaluate several existing estimation methods of odds ratio and propose bias‐corrected estimators for randomized multi‐stage trials, including randomized phase II cancer clinical trials. Through numerical studies, the proposed estimators are shown to have a smaller bias and a smaller mean squared error overall.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Randomized Controlled Trials as TopicResearch DesignBiasClinical Trials, Phase II as TopicHumansOdds RatioSample SizeLikelihood FunctionsModels, StatisticalData Interpretation, StatisticalNeoplasmsEarly Termination of Clinical Trials

Stichwörter der Autor:innen

futility stoppinggroup sequential designsodds ratiosuperiority stopping

Autor:innen und Institutionen

  • Department of Biostatistics and Bioinformatics, Duke University, Durham, North Carolina, USA.

ORCID-Profile: Sin-Ho Jung

Zitieren

APA

Cao, S., & Jung, S. H. (2024). Estimation of the odds ratio from multi‐stage randomized trials. Pharmaceutical Statistics. https://doi.org/10.1002/pst.2378

Vancouver

Cao S, Jung SH. Estimation of the odds ratio from multi‐stage randomized trials. Pharmaceutical Statistics. 2024. doi:10.1002/pst.2378

BibTeX
@article{Cao2024,
  author = {Cao, Shiwei and Jung, Sin-Ho},
  title = {Estimation of the odds ratio from multi‐stage randomized trials},
  journal = {Pharmaceutical Statistics},
  year = {2024},
  doi = {10.1002/pst.2378}
}
Kostenlos starten →